Hemosiderosis
Symptoms, Doctors, Treatments, Advances & More

Learn About Hemosiderosis

What is the definition of Hemosiderosis?
Accumulation of iron in internal organs.
What are the alternative names for Hemosiderosis?
  • Hemosiderosis
Who are the top Hemosiderosis Local Doctors?
Advanced in Hemosiderosis
Family Medicine
Advanced in Hemosiderosis
Family Medicine

Texas Health Family Care

10900 Founders Way, Suite 103, 
Fort Worth, TX 
Languages Spoken:
English
Offers Telehealth

Dr. William Drake has been serving the primary care needs of North Texas families since 1995. He is focused on providing quality preventative medicine as the first line of defense for patients of all ages. Dr. Drake is dedicated to serving his patients by providing personalized health and wellness services through exemplary care, education and research. He is especially passionate about research and treatments in the areas of juvenile and adult diabetes.Dr. Drake earned his medical degree from the University of Michigan in East Lansing. He completed his family medicine residency at The University of Texas Health Science Center at San Antonio. Dr. Drake is a Fellow of the American Academy of Family Physicians and a member of the American Diabetes Association, Juvenile Diabetes Research Foundation, Tarrant County Medical Society, Texas Academy of Family Physicians and Texas Medical Association. Dr. Drake is rated as an Advanced provider by MediFind in the treatment of Hemosiderosis. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Cirrhosis, Xanthoma, Familial Combined Hyperlipidemia, and High Cholesterol.

Advanced in Hemosiderosis
Advanced in Hemosiderosis
Referral may be required

Vince Lombardi Cancer Clinic

2845 Greenbrier Rd, Ste 250, 
Green Bay, WI 
Languages Spoken:
English
Offers Telehealth

Demet Yasar is a Hematologist practicing medicine in Green Bay, Wisconsin. Dr. Yasar is rated as an Advanced provider by MediFind in the treatment of Hemosiderosis. She is also highly rated in 51 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS). Dr. Yasar is board certified in American Board Of Internal Medicine, Hematology.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Hemosiderosis
Elite in Hemosiderosis
Referral may be required
Cale Street, 
London, ENG, GB 

Dudley Pennell practices practicing medicine in London, United Kingdom. Mr. Pennell is rated as an Elite expert by MediFind in the treatment of Hemosiderosis. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Hemosiderosis, Dilated Cardiomyopathy (DCM), Cardiomyopathy, Heart Transplant, and Heart Bypass Surgery.

What are the latest Hemosiderosis Clinical Trials?
Impact de la Surcharge en Fer Sur l'Incidence Des Complications hépatiques Chez Les Patients allogreffés de Cellules Souches hématopoïétiques à Plus de 10 Ans de la Greffe

Summary: This single-center, non interventional cohort study investigates whether chronic iron overload influences the incidence of liver complications in adults who are at least 10 years beyond allogeneic hematopoietic stem cell transplantation (allo HSCT). Approximately 400-500 survivors transplanted at Hôpital Saint Louis between January 2004 and December 2014 will be evaluated. Transplant characteristi...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Leflunomide is Safe and Effective for the Induction and Maintenance of Idiopathic Pulmonary Hemosiderosis Remission

Summary: The goal of this clinical trial is to compare Leflunomide in Idiopathic pulmonary hemosiderosis. The main questions it aims to answer are: * The efficacy and safety of Leflunomide in Idiopathic pulmonary hemosiderosis * The mechanism of leflunomide in treating Idiopathic pulmonary hemosiderosis Participants will be treated with leflunomide plus stroid. A comparison group: Researchers will compare ...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center